Cargando…

Comparison of the prognostic value of platelet-based prognostic models in patients with malignant hepatic tumors after TACE therapy

PURPOSE: To investigate the prognostic value of 17 platelet-based prognostic scores in patients with malignant hepatic tumors after TACE therapy. METHODS: In total, 92 patients were divided into death group and survival group according to long-term follow-up results. The AUC was calculated to determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Qian Cheng, Hu, Chen Liang, Wang, Yan Yan, Zhou, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756010/ https://www.ncbi.nlm.nih.gov/pubmed/31531530 http://dx.doi.org/10.1590/s0102-865020190070000010

Ejemplares similares

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies
por: Loosen, Sven H., et al.
Publicado: (2019)

Prognostic value of sarcopenic visceral obesity in hepatocellular carcinoma treated with TACE
por: Li, Yuxuan, et al.
Publicado: (2023)

Relationship between platelet-based models and the prognosis of patients with malignant hepatic tumors
por: Hu, Chen-Liang, et al.
Publicado: (2020)

Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma
por: Hu, Hao, et al.
Publicado: (2016)

Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis
por: Yao, Man, et al.
Publicado: (2022)

Prognostic value of des-γ-carboxyprothrombin in patients with AFP-negative HCC treated with TACE
por: Sun, Hanyao, et al.
Publicado: (2022)

Prognostic value of tumor markers in malignant melanoma
por: Treskova, Inka, et al.
Publicado: (2014)

Predictive and prognostic values of preoperative platelet parameters in patients with gynecological tumors
por: Yang, Wei, et al.
Publicado: (2020)

The Prognostic Value of (18)F-FDG PET/CT for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization (TACE)
por: Ma, Wenhui, et al.
Publicado: (2014)

Prognostic value of platelet combined with serum procalcitonin in patients with sepsis
por: Chen, Jianhui, et al.
Publicado: (2023)

Comparison of the Prognostic Value of Platelet-Related Indices in Biliary Tract Cancer Undergoing Surgical Resection
por: Sun, Lejia, et al.
Publicado: (2021)

Prognostic value of mean platelet volume to plateletcrit ratio in patients with osteosarcoma
por: Gou, Bo, et al.
Publicado: (2019)

Prognostic value of FOXQ1 in patients with malignant solid tumors: a meta-analysis
por: Cui, Xiaohai, et al.
Publicado: (2017)

Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study
por: Wang, Yang, et al.
Publicado: (2018)

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer
por: Zhang, Yan, et al.
Publicado: (2018)

Prognostic value of high on-treatment platelet reactivity
por: Doğan, Ali, et al.
Publicado: (2017)

Prognostic values of procalcitonin and platelet in the patient with urosepsis
por: Jiang, Ling, et al.
Publicado: (2021)

Correction: Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study
por: Wang, Yang, et al.
Publicado: (2018)

Development and Validation of TACE Refractoriness-Related Diagnostic and Prognostic Scores and Characterization of Tumor Microenvironment Infiltration in Hepatocellular Carcinoma
por: He, Qifan, et al.
Publicado: (2022)

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies
por: Loosen, Sven H., et al.
Publicado: (2023)

Comparison of Efficacy and Safety of TACE Combined with Microwave Ablation and TACE Combined with Cryoablation in the Treatment of Large Hepatocellular Carcinoma
por: Wang, Yujia, et al.
Publicado: (2022)

Prognostic efficacy and prognostic factors of TACE plus TKI with ICIs for the treatment of unresectable hepatocellular carcinoma: A retrospective study
por: Han, Ziqiang, et al.
Publicado: (2022)

Diagnostic and prognostic role of mean platelet volume and mean platelet volume/platelet ratio in patients with primary malignant bone tumor
por: Sökmen, Fevzi Coşkun, et al.
Publicado: (2021)

TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma
por: Granito, Alessandro, et al.
Publicado: (2021)

Prognostic Values of Platelet-Associated Indicators in Resectable Cervical Cancer
por: Wang, Jing-mei, et al.
Publicado: (2019)

Prognostic value of tumor necrosis in gastrointestinal stromal tumor: A meta-analysis
por: Yi, Mengshi, et al.
Publicado: (2019)

Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE
por: Wang, Tian-Cheng, et al.
Publicado: (2021)

Prognostic value of the DNA integrity index in patients with malignant lung tumors
por: Chudasama, Dimple Y., et al.
Publicado: (2018)

Prognostic values of platelet-associated indicators in advanced breast cancer
por: Lu, Yu-Jie, et al.
Publicado: (2019)

Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer
por: Cai, Du, et al.
Publicado: (2019)

Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: A meta-analysis
por: Ding, Wei, et al.
Publicado: (2018)

Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis
por: Yuan, Yuan, et al.
Publicado: (2020)

The Expression and Prognostic Value of Cancer Stem Cell Markers, NRF2, and Its Target Genes in TAE/TACE-Treated Hepatocellular Carcinoma
por: Tseeleesuren, Duurenjargal, et al.
Publicado: (2022)

The prognostic role of the AST/ALT ratio in hepatocellular carcinoma patients receiving thermal ablation combined with simultaneous TACE
por: Wang, Feihang, et al.
Publicado: (2023)

The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases
por: Vogl, Thomas J., et al.
Publicado: (2022)

Prognostic Values of Platelet Distribution Width and Platelet Distribution Width-to-Platelet Ratio in Severe Burns
por: Lin, Jian-Chang, et al.
Publicado: (2022)

Prognostic Value and Biological Function of Galectins in Malignant Glioma
por: Zhu, Hongtao, et al.
Publicado: (2022)

A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE
por: Hu, Shuyang, et al.
Publicado: (2021)

The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
por: Liu, Shun, et al.
Publicado: (2021)

CT-radiomics and clinical risk scores for response and overall survival prognostication in TACE HCC patients
por: Bernatz, Simon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0sris9msobre8hc5hjl8bkjvq8